The Ehlers-Danlos syndrome (EDS) is a heterogen�ous group of generalized connective tissue disorders, the major manifestations of which are skin fragility, skin hyperextensibility, andjoint hypermobility. The clini cal and molecular definition of more than ten types of EDS has, more than ever, emphasized the importance of correct diagnosis because the natural history and mode of inheritance dift"er among the types. Unfortu nately, much of the older literature does not dift"eren tiate among the types clearly, and in some instances the life-threatening complications ofEDS type IV may be cited as characteristic of the syndrome as a whole.
30 years ago when the core of the modern classification was developed by Barabas. Since then it was extended by Beighton et ai, and then amplified with the insights provided by biochemical and molecular genetic stud ies. Clinical studies were sufficient initially to distin guish five types ofEDS; biochemical studies identified four additional types, EDS type VI, EDS type VII, EDS type IX, and EDS type X, whereas clinical criteria dis tinguished EDS type vm.
In the following sections, the clinical manifestations of the dift"erent forms ofEDS are summarized and the known biochemical and molecular genetic features are emphasized.] Invest DermatoI103:47S-52S, 1994
EDS type I have very soft, markedly hyperextensible skin that bruises easily and heals with broad, thin scars (cigarerte-paper scars). Scarring occurs typically on the forehead, under the chin, on the elbows and knees, and down the shins. Individuals with EDS type II have less striking involvement of skin but, nonetheless, have scars in the same characteristic distribution. Individuals with EDS type III may have few skin manifestations.
The clues to the molecular basis of these cornmon forms ofEDS are few and far between. Recently cells from two individuals, who have joint hypermobility, hyperextensible skin, and mild aortic root dilatation, were found to secrete proal(l) trimers because they failed to make the proa2(1) chains of type I procollagen [11] . Al though these individuals fit the EDS type II clinical description with respect to skin and joint findings, the presence of aortic dila tion and the apparent recessive inheritance of the condition distin guishes a unique variant of EDS. Their clinical presentation also distinguishes them from a unique child with a form of osteogenesis imperfecta whose cells fail to produce proa2(I) chains. The bio chemical distinctions among these individuals need to be identified.
Despite these intriguing clues, the molecular defects that underlie EDS types I,ll, and III are not known. Genetic linkage studies have excluded the candidate COLlAl and COLlA2 genes that encode the chains of type I procollagen, the most abundant protein in skin, as well as the COL2Al and COL3Al genes [12] . Biomechanical studies, suggestive of abnormal collagen in dermis [13] , and electron microscopic studies of dermis that have demonstrated larger than normal collagen fibrils, frequent composite fibrils, and smaller than normal collagen fibers [14, 15] , nonetheless implicate collagen ab normalities in fibrillogenesis or fibril stabilization as potential ef fe cts of the underlying mutation. With the ability to scan rapidly well-spaced and highly informative loci in the genome, it would not be surprising if the gene locus (loci) that result in these disorders will be identified shortly and could include genes that encode pro-0022-202Xj94jS07.00 Copyright © 1994 by The Society for Investigative Dermatology, Inc. The life span of individuals with EDS type IV is generally shorter than that of their unaffected sibs with the mean age of death being in the early 30s for women and slightly older for men [201. Deaths in the third through the fifth decades are the rule with survival beyond 50 years of age being apparently rare.
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EDS type IV results from heterozygosity for mutations in the COL3Al gene, so that the condition is inherited in an autosomal dominant fashion [27, 28] . Although it has been proposed that auto somal recessive forms also exist [29, 30] , these must be rare. Asymp tomatic parental mosaicism for the mutation has been documented in three families and it is this, rather than recessive inheritance. that probably accounts for sibling recurrence in the absence of parental involvement [31] [32] [33] . Because of the autosomal dominant mode of transmission, segregation studies using polymorphic restriction The single letter code for amino acids is used. The mutation designated as G l36R indicates that glycine at position 135 of the triple helix is replaced by arginine. B,location of multi-exon deletions, and exon-skipping mutations in the COL3Al gene.
sites in the COL3Al gene, can be used to identify individuals with the affected allele and has the potential for use in prenatal diagnosis
[28].
EDS type IV results from point mutations that produce substitu tion of glycine residues within the triple-helical domain, from exon-ski p ping mutations within the triple-helical domain, and from multi-exon deletions, all within the COL3Al gene. Almost a dozen discrete substitutions for glycine residues within the triple helix have been reported [31,32,34 -43] (see Fig 1) . Exon suggested that this entity does not currently warrant a distinct des ignation. Until the gene is located, or the biochemical abnormality is found, this controversy cannot be resolved.
EHLERS-DANLOS SYNDROME TYPE VI, AN AUTOSOMAL RECESSIVE CONDITION DUE TO DEFECTS IN LYSYL HYDROXYLASE
EDS type VI, an autosomal recessive condition, was the first of the true disorders of collagen structure and biosynthesis to be identified [6, 61] . The clinical features initially identified included soft, hyper extensible skin, joint hypermobility, scoliosis, ocular fragility, a marfanoid habitus that have more recently been supplemented by a propensity for bleeding from major vessels, the frequency of which remains uncertain, and motor delay [62] . The disorder is uncom mon and fewer than two dozen individuals have been identified [6, [61] [62] [63] [64] [65] [66] [67] [68] [69] . The EDS type VI phenotype results from markedly decreased activity of the enzyme lysyl hydroxylase [6] . The variation in the enzyme activity in the cells from aff'ected individuals suggests that there is heterogeneity in the mutations in the gene. The recent isolation and characterization of the lysyl hydroxylase gene has facilitated mutation detection. In the first two families studied, ap parent homozygosity for mutations is probably consistent with pa rental consanguinity. In one [70] there was homozygosity for a stop codon at residue 319 (R319X), and in the other [71] there was an internal duplication of 180 bp within the coding sequence of the eDNA that apparently led to marked decrease in enzyme function.
Prenatal diagnosis of EDS type VI by measurement of lysyl hy droxylase enzyme activity in amniotic fluid cells has been attempted in one family at risk. The birth of an unaff'ected but heterozygous infant was correctly predicted [65] . The presence of informative markers in the lysyl hydroxylase gene should facilitate diagnosis in families in which an affected child has been born.
The post-translational hydroxylation of lysyl residues in types I and III collagen in skin is reduced, but that of type II collagen in cartilage is normal or near normal. The residual enzyme appears to be almost normally efficient in the hydroxylation oflysyl residues in type IV collagen [72] . Diff'erential lysyl hydroxylation of collagen types in individuals with EDS type VI could be explained by difFer ent affinities of a single enzyme for the specific collagens or by the presence of collagen type-specific lysyl hydroxylases; only a sin g le enzyme has been identified to date.
Hydroxylation of lysyl residues in type 1 collagen is vital for the formation of normal crosslinks among collagen molecules [73] The major com p lications of EDS type VIlA and VlIB are those which result from lon g -term instability of joints and failure to make a normal hip joint. Interestingly, bone fractures may be increased in some families with EDS type VIlA or VlIB.
EHLERS-DANLOS SYNDROME TYPE VII, NEW UNDERSTANDINGS OF THE
At first, EDS type VII was thought to result from abnormalities in the enzyme that cleaves the N-terminal propeptide extension from type I procollagen [7] , probably because of the then recent discovery of the recessively inherited disorder, dermatosparaxis. in cattle [76] . However, further analysis of collagens synthesized by cells from several affected individuals demonstrated that the mutations in volve the cleavage sites of the substrate proal (I) and proa2(I) chains [77 -80] . In all patients with EDS type VIlA or VIIB in which the mutation has been characterized, the mRNA from the mutant allele lacks some or all of the sequence of exon 6. the domain that encodes the cleavage site for the N-proteinase. The genomic mutations are heterogeneous: in six, substitutions in the consensus splice sites surrounding exon 6 of the COLlA2 gene [81] [82] [83] [84] [85] are the cause, whereas in two others the mutations are in the COLIAI gene [86] . Deletion of all or part of the exon that encodes the N-terminal procollagen peptidase cleavage site has several effects on the mole cule: it deletes the site of cleavage in one chain, it throws into disarray the N-terminal cleavage site in molecules that incorporate the abnormal chain, and it removes a lysyl residue in the telopeptide extension that is frequently hydroxylated and involved in intermo lecular crosslinks. It is likely that the mutations alter crosslink for mation and fibrillogenesis and so decrease tensile strength of most tissues made up principally of type I collagen.
Although a recessively inherited defect in procollagen conversion had been identified in cattle in 1971, the same condition was not identified in humans for more than 20 years [87-89]. The three children who have been identified are very similar and have fragile skin that bruises very easily, extremely soft, doughy skin, marked joint laxity with delayed motor milestones, blue sclerae, micro gnathia, large umbilical hernia, and mild hirsuitism. Intellectual development is normal. One child has had a central nervous system hemorrhage.
Collagen fibrils in skin from the affected children have a charac teristic hieroglyphic appearance in cross-section and a ribbon-like appearance in longitudinal section. This reflects the presence of 50S BYERS little normal collagen, and an abundance of molecules in which the amino-terminal propeptide has been left in place, because the N proteinase that normally removes the peptide is missing, to disturb normal molecular interaction during fibril formation.
EHLERS-DANLOS SYNDROME TYPE VIII EDS type VIII is characterized by bruising, soft, and hyperextensi ble skin, hypermobile joints, and periodontal disease [90, 91] Although the male subjects with this disorder are of normal height, skeletal deformities such as short humeral bones, partial radio-ulnar synostosis, and short broad clavicles are apparent on clinical and radiologic examination. Mild chronic diar rhea and orthostatic hypotension may be common. Like infants with the Menkes kinky hair syndrome, affected male subjects have a defect in distribution of intracellular copper to the apo-enzymes into which it is integrated [95] [96] [97] . The major mea sured effect of this defect is a decrease in the activity of the copper dependent enzyme, lysyl oxidase, which catalyzes the oxidation of lysyl residues in collagen and elastin to form crosslink precursors. EHLERS-DANLOS SYNDROME TYPE X EDS type X is thought to be inherited in an autosomal recessive fashion and characterized by mild joint hypermobility and easy bruising. The disorder appears to result from an alteration in fibro nectin that interferes with normal platelet aggregation [102] . Only one family has been identified to date and the defect in fibronectin has never been identified.
SUMMARY
The clinical heterogeneity within the Ehlers-Danlos syndrome is due, in part, to mutations in several different genes. Thus type I collagen genes (COLIAl and COLtA2). the type III collagen gene (COL3Al).lysyl hydroxylase. procollagen N-protease, the copper transport gene, and fibronectin have each been implicated in differ ent forms ofEOS. For some forms ofEDS that historically acquired an individual designation (e.g., EOS type V and EOS type X) there must be some concern about the legitimacy in maintaining such distinctions and there is considerable need to pursue molecular ge netic studies in the known families. For the common forms ofEOS it has been a disappointing decade of relatively little search and unproductive searches when they have been completed. The new generation of molecular markers does, however. promise that if appropriate families can be identified then rapid progress can be made in identifying the candidate genes. These discoveries should further enlighten us about the manner in which the dermis and other connective tissues are assembled.
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